Rare diseases

This year I read the Regulation of the European Parliament about orphans drugs. That day I and researched more information about this the subject. Pharmaceuticals companies said say that there aren't many drugs to treat rare diseases don’t have many medicines because it don’t have not many people have them and the researches are is very expensive. Consequently, orphans drugs are very expensive and families can’t buy it. too expensive for families to buy.
Scientists prefer to research common diseases, for example diabetes or cancer.

Rare diseases

This year I read the Regulation of the European Parliament about orphans drugs. That day I searched for information about this subject. Pharmaceuticals Pharmaceutical companies said say that rare diseases don’t have many medicines there aren't many drugs to treat rare diseases because it don’t have not many people have them and researches are is very expensive. Consequently, orphans drugs are very expensive and families can’t afford to buy it them.
Scientists prefer to research common diseases, for example diabetes or cancer.

Rare diseases

This year I read the Regulation of the European Parliament about orphans and pharmaceutical drugs. That day I searched for information about this subject. Pharmaceuticals companies have said that there isn't much treatment available for rare diseases don’t have many medicines because it don’t have there aren't many people who suffer from them and researches are is very expensive. Consequently, orphans drugs for orphans are very expensive and families can’t buy afford it them.
Scientists prefer to research common diseases, for example diabetes or cancer.